US Patent 7879327 Medicament for treating cancer
Patent 7879327 was granted and assigned to Dainippon Sumitomo on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+203 characters)
Article
Patent abstract
A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Akemi Baba0
Mitsuharu Hanada0
Toshihiro Noguchi0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07879327 Medicament for treating cancer US Patent 7879327 Medicament for treating cancer
Infobox
Patent Number
078793270
Patent Number
78793270
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078793270
Date of Patent
February 1, 2011
0Patent Application Number
117612640
Date Filed
June 11, 2007
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07879327 Medicament for treating cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07879327
Date of patent
February 1, 2011
Patent application number
11761264
Date Filed
June 11, 2007
Patent primary examiner
Find more entities like US Patent 7879327 Medicament for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
